Miracle Mile Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Buy
4,244
+125
+3% +$12.8K 0.01% 637
2025
Q4
$437K Buy
4,119
+43
+1% +$4.98K 0.01% 612
2025
Q3
$518K Sell
4,076
-77
-2% -$9.17K 0.01% 542
2025
Q2
$509K Buy
4,153
+310
+8% +$35.4K 0.01% 476
2025
Q1
$389K Buy
3,843
+8
+0.2% +$781 0.01% 473
2024
Q4
$354K Buy
3,835
+112
+3% +$11K 0.01% 496
2024
Q3
$360K Buy
3,723
+23
+0.6% +$2.07K 0.01% 395
2024
Q2
$317K Hold
3,700
0.01% 396
2024
Q1
$306K Hold
3,700
0.01% 404
2023
Q4
$247K Hold
3,700
0.01% 420
2023
Q3
$248K Hold
3,700
0.01% 421
2023
Q2
$251K Hold
3,700
0.01% 446
2023
Q1
$200K Hold
3,700
0.01% 481
2022
Q4
$221K Buy
+3,700
New +$201K 0.01% 457

Other funds holding EHC

Miracle Mile Advisors's EHC Position: Q1 2026 in Review

Miracle Mile Advisors increased its Encompass Health (EHC) stake by 3% in Q1 2026, buying an estimated $12.8K and bringing the position to 4,244 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #637.

Miracle Mile Advisors first reported a position in EHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $518K in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Miracle Mile Advisors held 4,244 shares of Encompass Health worth $411K as of Q1 2026.
  • Miracle Mile Advisors bought 125 Encompass Health shares in Q1 2026, an estimated $12.8K.
  • Encompass Health made up 0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #637 holding.
  • Miracle Mile Advisors first reported a position in Encompass Health in Q4 2022 and has held it in 14 quarters since.
  • Miracle Mile Advisors's Encompass Health position peaked at $518K in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.